Publications, Pharmaceutical

A pre-filled syringe platform for vaccines and large volume biologics

Choosing appropriate packaging for a drug is essential since interactions between drug and container can compromise patient safety. This is especially true for biologics and vaccines. This article introduces Aptar Pharma’s PremiumCoat® platform focusing on its application in the manufacture of prefilled syringes. Prefilled syringes are prized for their ability to limit drug waste and for easy administration at the point of use, a factor that makes them useful for seasonal vaccination of the type that may prove necessary for the long-term management of COVID-19. The PremiumCoat® 1 – 3ml plunger format combines a pure bromobutyl formulation with proven ETFE film technology to minimize leachables. It is particularly useful for vaccines and large-volume biologics and facilitates vial-to-prefill projects. Experimental data illustrate key aspects of the system’s performance.

Download Publication
Author(s): Sébastien Cordier Dr. Laure-Hélène Guillemot Audrey Chardonnet
Drug Development & Delivery
5 Oct 2021

This Might Also Be of Interest

18 Jan 2024

Exploring Extractable and Leachable Testing Strategies for Parenterals

Publications, Pharmaceutical, Innovation & Insights, Market Insights, Product Solutions

Read More
18 Dec 2023

Elevating Medication Adherence and Clinical Outcomes with Connected Drug Delivery

Publications, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
13 Oct 2023

Aptar Pharma Injectable Expansion – Capacity, Capabilities and Partnership

Publications, Pharmaceutical, Market Insights, Product Solutions

Read More
13 Oct 2023

Injectable Primary Packaging support compliance with Annex 1 Revision

Publications, Pharmaceutical, Brand Differentiation, Market Insights, Product Solutions

Read More
1 2 3 4 5 6 14

Request Access

Close

Requesting access to A pre-filled syringe platform for vaccines and large volume biologics.

  • This field is for validation purposes and should be left unchanged.
Back To Top